by rss feed | Oct 8, 2023 | Neurona Therapeutics, News Feeds, NRTX-1001, VX-880, weekly reads
People often ask me what are the most promising stem cell therapies in development and new data suggest we should add stem cells for epilepsy to the list based on work by Neurona Therapeutics. I’ll start off the weekly recommended reads with this new mouse paper...
by rss feed | Jul 26, 2022 | biotechs, News, News Feeds, Semma, stem cells for diabetes, Vertex, ViaCyte, VX-880
When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade....
